NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lindmik Pharmaceutical (Suzhou) Co., Ltd.

Lindmik Pharmaceutical (Suzhou) Co., Ltd.

Private
SuzhouHealthcare & Life Scienceshttps://lindmik.com/

Last Round

Early Funding

Jun 7, 2024

Total Funding Raised

$14M

Company Overview

Lindmik Pharmaceutical (Suzhou) Co., Ltd. is a pharmaceutical company that focuses on the research and development, production, and sales of innovative pharmaceutical preparations, particularly in the field of transdermal drug delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transdermal drug delivery systemsspecialty pharmadrug delivery technologydrug formulationanalgesic patchpain patchgel patchespharmaceutical licensingvertically integrated pharmaFlurbiprofen gel pastenano-based drug deliverymicrospheres drug delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lindmik Pharmaceutical (Suzhou) Co., Ltd. Comparables

Compare Lindmik Pharmaceutical (Suzhou) Co., Ltd. with similar companies based on industry and business-model similarity.

Lindmik Pharmaceutical (Suzhou) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sino Biopharmaceutical
83%
Hunan Jiudian Pharmaceutical Co Ltd
71%
Hisamitsu Pharmaceutical Co., Inc.
68%

Lindmik Pharmaceutical (Suzhou) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 7, 2024
Pre-A RoundSep 29, 2021
AngelDec 1, 2020

Lindmik Pharmaceutical (Suzhou) Co., Ltd. Investors

Notable investors and investment history

Lindmik Pharmaceutical (Suzhou) Co., Ltd. investors
InvestorRounds
Fuhui Venture CapitalEarly Funding
CCIC CapitalEarly Funding
Suzhou Wuzhong Biological Medicine Industry Investment CompanyAngel, Pre-A Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 7, 2024

    $14M raised, led by CCIC Capital.

  • Sep 29, 2021

    $3.1M round led by Suzhou Wuzhong Biological Medicine Industry Investment Company

Lindmik Pharmaceutical (Suzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lindmik Pharmaceutical (Suzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lindmik Pharmaceutical (Suzhou) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Year Founded2019
Last FundingJun 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.